Dorigo O - Search Results

1

Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.

Sobol RE, Royston I, Fakhrai H, Shawler DL, Carson C, Dorigo O, Gjerset R, Gold DP, Koziol J, Mercola D, et al. Sobol RE, et al. Among authors: dorigo o. Hum Gene Ther. 1995 Feb;6(2):195-204. doi: 10.1089/hum.1995.6.2-195. Hum Gene Ther. 1995. PMID: 7734519 No abstract available.

2

Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma.

Shawler DL, Dorigo O, Gjerset RA, Royston I, Sobol RE, Fakhrai H. Shawler DL, et al. Among authors: dorigo o. J Immunother Emphasis Tumor Immunol. 1995 May;17(4):201-8. doi: 10.1097/00002371-199505000-00002. J Immunother Emphasis Tumor Immunol. 1995. PMID: 7582256

3

Interleukin-2 gene therapy in a patient with glioblastoma.

Sobol RE, Fakhrai H, Shawler D, Gjerset R, Dorigo O, Carson C, Khaleghi T, Koziol J, Shiftan TA, Royston I. Sobol RE, et al. Among authors: dorigo o. Gene Ther. 1995 Mar;2(2):164-7. Gene Ther. 1995. PMID: 7719933

4

Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.

Gjerset RA, Fakhrai H, Shawler DL, Turla S, Dorigo O, Grover-Bardwick A, Mercola D, Wen SF, Collins H, Lin H, et al. Gjerset RA, et al. Among authors: dorigo o. In Vitro Cell Dev Biol Anim. 1995 Mar;31(3):207-14. doi: 10.1007/BF02639435. In Vitro Cell Dev Biol Anim. 1995. PMID: 7757303

5

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I, Sobol RE. Fakhrai H, et al. Among authors: dorigo o. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2909-14. doi: 10.1073/pnas.93.7.2909. Proc Natl Acad Sci U S A. 1996. PMID: 8610141 Free PMC article.

6

Construction and characterization of retroviral vectors for interleukin-2 gene therapy.

Fakhrai H, Shawler DL, Van Beveren C, Lin H, Dorigo O, Solomon MJ, Gjerset RA, Smith L, Bartholomew RM, Boggiano CA, Gold DP, Sobol RE. Fakhrai H, et al. Among authors: dorigo o. J Immunother. 1997 Nov;20(6):437-48. doi: 10.1097/00002371-199711000-00003. J Immunother. 1997. PMID: 9409449

7

Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function.

Dorigo O, Turla ST, Lebedeva S, Gjerset RA. Dorigo O, et al. J Neurosurg. 1998 Mar;88(3):535-40. doi: 10.3171/jns.1998.88.3.0535. J Neurosurg. 1998. PMID: 9488309

8

Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.

Dorigo O, Shawler DL, Royston I, Sobol RE, Berek JS, Fakhrai H. Dorigo O, et al. Gynecol Oncol. 1998 Nov;71(2):204-10. doi: 10.1006/gyno.1998.5151. Gynecol Oncol. 1998. PMID: 9826461

9

Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.

Shawler DL, Bartholomew RM, Garrett MA, Trauger RJ, Dorigo O, Van Beveren C, Marchese A, Ferre F, Duffy C, Carlo DJ, Sherman LA, Gold DP, Sobol RE. Shawler DL, et al. Among authors: dorigo o. Clin Exp Immunol. 2002 Jul;129(1):99-106. doi: 10.1046/j.1365-2249.2002.01863.x. Clin Exp Immunol. 2002. PMID: 12100028 Free PMC article.

10

Interleukin-2 (IL-2) gene therapy with allogeneic fibroblasts in the CT-26 model of murine colorectal carcinoma.

Shawler D, Dorigo O, Vanbeveren C, Bartholomew R, Fakhrai H, Sobol R. Shawler D, et al. Among authors: dorigo o. Oncol Rep. 1997 Jan-Feb;4(1):135-8. Oncol Rep. 1997. PMID: 21590028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters